EXTRAORDINARY REPORT · LISA RADAR · OBESITY

The regulatory door has opened. Price is what gives next.

Sixteen semaglutide applications are pending at Anvisa. Every approval redraws the pricing board in weeks, not quarters. The extraordinary report reads what that demands of anyone deciding portfolio right now.

READ THE EXTRAORDINARY REPORT

Independent intelligence on the Brazilian Life Sciences market.

BY LINE OF CARE: Unit of analysis
A1–D: Evidence taxonomy
100%: Independent of manufacturers

WHAT WE DELIVER

Two products. One editorial discipline.

RADAR ANCHORS THE LINE OF CARE · MONITOR KEEPS IT CURRENT

Lisa Radar

FOUNDATIONAL REPORT

Reads a whole line of care, not a molecule: market pyramid, cross-treatment competition, pipeline and price. Published yearly, or whenever an event redraws the competitive board.

Market pyramid and cross-treatment competition
Pipeline, approvals and price of every competitor
The reference piece that anchors the category

LEARN MORE

Lisa Monitor

CONTINUOUS LAYER

The recurring product: everything that changes between one Radar edition and the next, inside a perimeter defined with you and watched continuously.

Scope defined together
24-hour alert with the implication read
Dossiers and committee material on demand

LEARN MORE

PROPRIETARY INDICATOR

A single number for the direction of the market.

The Lisa Market Growth Forecast consolidates observable signals into a score from 0 to 100, indicating growth propensity over the next 12 months.

81ILLUSTRATIVE EXAMPLE

02040557085100

STRONG DECLINE LIKELYSTRONG GROWTH LIKELY

HOW THE SCORE IS BUILT

INSIGHTS

Published readings

VIEW ALL

REGULATORY

What changes when a generic can be compared to the national reference product

The opening of the regulatory pathway is not price news. It is portfolio news, and the clock on reacting has already started.

METHOD

Interpretation is the product.

Classified evidence

Every claim carries an A1-to-D seal and separates fact, inference, projection and recommendation.

Independence

No ties to manufacturers, distributors or funds. The reading has no side to defend.

Transparent correction

Divergences between editions are flagged in the Method section, never adjusted in silence.

Start with the extraordinary report.

The extraordinary edition of Lisa Radar · Obesity, free and with no commitment.

GET THE REPORT